According to the latest published report by Polaris Market Research the global cancer immunotherapy market size is expected to reach USD 117.82 billion by 2026 and growing at a CAGR of 9.3% from 2020 to 2026. The report “Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments Forecast, 2020 – 2026”gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing pool of patients and greater mortality rates through cancer worldwide have encourage the need for cancer immunotherapy. Cancer is the second leading cause mortalities in 2019, with continuous rise in the number of cancer patient across the globe, as per the report published by WHO. Furthermore, it is estimated that 1 out of 6 deaths occurs due to cancer every year across the globe. As per WHO, nearly one-third of the mortalities from cancer are due to 5 leading behavioral and dietary risk, which includes low fruit and vegetable intake, high body mass index, lack of physical activity, alcohol consumption, and tobacco use. Tobacco is one of the leading factors for the rise in the prevalence of cancer and mortalities that accounted to nearly 22% of the global population. Rising number of cancer patients is the major factor for the growth of global diagnostic biomarker market.
Request A Sample Report At : https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market/request-for-sample
Key players present in the Cancer Immunotherapy Market:
Amgen Inc., Astellas Pharma, Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., F. Hoffman La Roche, Merck and Co., Novartis, OSE Immunotherapeutics, among others
According to WHO, there were around 17.6 million cases related to cancer that increases to 18.1 million cases in 2018 and nearly 9.6 million mortalities. Cancer immunotherapy is widely used in treating prostate cancer, blood cancer, melanoma, lung, breast, colorectal and other chronic diseases. In the breast cancer segment, there is relatively higher demand for immunotherapy. The demand for immunotherapy in pulmonary cancer is also significantly increasing. Furthermore, the growing population of smokers and the alarming increase in urban air pollution are the main factors driving the market development. Therefore, increasing prevalence of cancer across the globe augmenting the global market for cancer immunotherapy.
Moreover, the global market for cancer immunotherapy is driven by a growing amount of approvals for new immunotherapy drugs. In the global cancer therapy industry, cancer immunotherapy has led to unprecedented changes. Over the past few years, cancer immunotherapy has generated fresh waves of optimism across the global oncology industry, which has unmasked enormous innovative potential. Studies now look for fresh goals and procedures to overcome the lapses in conventional treatment after years of jostling about the way the body can use its immune system. The paradigm shift in the management of cancer, relative to existing conventional therapies based on features like relatively long-lived effects, exceptional specificity and enhanced survival rates was brought about by the introduction of cancer immunotherapy. This has led to the accelerated growth of the global market.
Get Full Research Summary on Global Cancer Immunotherapy Market Analysis Available At: https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market
Within the Asia Pacific region, South Korea registered more than 200,000 new cancer cases a year. The increase in cancer cases in Asia can be accounted to the lifestyle and demographic changes. According WHO The incidences of colorectal cancer India were estimated about 1,85,000 in 2017. Japan accounted 1,49,000 cases in the 2017 according to national cancer institute. The average annual increase in government healthcare spending in the US is 4.5% and less than 1.5% in the European Union. However, Asian countries increase in healthcare expenditure is more than 6%, which is higher than the developed nations. Japan has the highest growth in the healthcare. Thus, creating significant opportunity in the market.
Table of Contents of Report:
Overview and Scope
Cancer Immunotherapy Market Insights
Cancer Immunotherapy Market Size and Forecast by Type
- Monoclonal Antibodies,
- Cancer Vaccines,
- Check Point Inhibitors & Immunomodulators
Cancer Immunotherapy Market Size and Forecast by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Head & Neck Cancer
Cancer Immunotherapy Market Size and Forecast by End-user
Cancer Immunotherapy Market Size and Forecast by Region
- North America (U.S., Canada)
- Europe (Germany, UK, France, Italy, Spain)
- Asia Pacific (China, South Korea, Japan, India)
- Latin America (Brazil, Mexico, Colombia)
- Middle East & Africa (Saudi Arabia, South Africa, Israel, UAE)
Have Questions? Or make an Inquiry before buying this report Speak to Our Industry Expert: https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market/speak-to-analyst
List of Tables
Table 1 Global cancer immunotherapy market (USD Billion) 2015 – 2026
Table 2 Global cancer immunotherapy market by type, 2015 – 2026 (USD Billion)
Table 3 Global cancer immunotherapy market by application, 2015 – 2026 (USD Billion)
Table 4 Global cancer immunotherapy market by end-user, 2015 – 2026 (USD Billion)
Table 5 Global cancer immunotherapy market by region 2015 – 2026 (USD Billion)
List of Figures
FIG 1. Market snapshot
FIG 2. Market segmentation & scope
FIG 3. Global Cancer Immunotherapy market size and growth prospects, 2015 – 2026
FIG 4. Value chain analysis
FIG 5. Cancer Immunotherapy market dynamics
Direct Purchase Licensed Copy Of Cancer Immunotherapy Market : https://www.polarismarketresearch.com/checkouts/6191
Monoclonal Antibodies (mAbs) Market [By Product Type (Fully Human, Murine, Chimeric); By Production System (Mammalian Cell Culture, Microbial Fermentation); By Indication (Cancer, Inflammation, Cardiovascular diseases, Transplant Rejection, Respiratory and Infectious diseases); By Technology Platforms (Transgenic-Mouse, Antibody Drug Conjugate, Phage-Display); By Target Mechanism of Action (CGRP, HER2, CTLA4, TNF alpha, EGFR, VEGF, Anti CD, Anti IL, IgGs, PD-1/PD-L1), By Care Delivery Setting; By Drug Types & By Region]: Market Size & Forecast, 2017 – 2026
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers.
Polaris Market Research